Jun Zhao

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

Tony Mok, Yi‐Long Wu, Iveta Kudaba et al. · The Lancet · 2019 · 3.3K citations · Full text

Medicine, Oncology, Pharmacology +15

Antagonistic HLH/bHLH Transcription Factors Mediate Brassinosteroid Regulation of Cell Elongation and Plant Development in Rice and<i>Arabidopsis</i>     

Liying Zhang, Ming‐Yi Bai, Jinxia Wu et al. · The Plant Cell · 2009 · 495 citations · Full text

Life Sciences, Plant Biology, Plant Sciences +15

Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC

Shugeng Gao, Ning Li, Shun‐Yu Gao et al. · Journal of Thoracic Oncology · 2020 · 415 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Two Putative BIN2 Substrates Are Nuclear Components of Brassinosteroid Signaling

Jun Zhao, Peng Peng, Robert J. Schmitz et al. · PLANT PHYSIOLOGY · 2002 · 251 citations · Full text

Life Sciences, Plant Biology, Plant Sciences +14

BIN2 Functions Redundantly with Other Arabidopsis GSK3-Like Kinases to Regulate Brassinosteroid Signaling    

Zhenyan Yan, Jun Zhao, Peng Peng et al. · PLANT PHYSIOLOGY · 2009 · 222 citations · Full text

Life Sciences, Plant Biology, Plant Sciences +14